Trial intelligence / Profile preview

Promethazine versus alprazolam for preoperative anxiety before lumbar disc surgery

IRCT20260709070112N1Phase 3Not yet recruiting

Sponsor
Kermanshah University of Medical Sciences
Start
Nov 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of promethazine and alprazolam in anxiety disorder (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Stress level before and after sedation, Blood pressure before and after sedation and 3 more. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

promethazinealprazolam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on IRCT20260709070112N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260709070112N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call